Asymmetric dimethylarginine as a novel independent risk factor for cardiovascular disease in hemodialysis patients

被引：0
|
作者：
Cibulka, R. [1 ]
Siroka, R. [1 ]
Rajdl, D. [1 ]
Racek, J. [1 ]
机构：
[1] Charles Univ Hosp, Inst Clin Biochem & Hematol, Plzen, Czech Republic
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2006年 / 7卷 / 03期
关键词：
D O I：
10.1016/S1567-5688(06)81215-8
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
TuP10515
引用
收藏
页码：298 / 298
页数：1
相关论文
共 50 条
  • [1] Asymmetric dimethylarginine as a novel independent risk factor for cardiovascular disease in haemodialysis patients
    Vesela, Eugenie
    Siroka, Romana
    Eiselt, Jaromir
    Malanova, Lada
    Racek, Jaroslav
    Trefil, Ladislav
    Rajdl, Daniel
    Cibulka, Roman
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 435 - 435
  • [2] Asymmetric dimethylarginine:: A cardiovascular risk factor in renal disease?
    Fliser, D
    Kielstein, JT
    Haller, H
    Bode-Böger, SM
    KIDNEY INTERNATIONAL, 2003, 63 : S37 - S40
  • [3] Asymmetric dimethylarginine as cardiovascular risk factor
    Galan, Amparo
    Formiguera, Xavier
    Rey-Joly, Celestino
    MEDICINA CLINICA, 2008, 131 (07): : 271 - 275
  • [4] The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor
    Böger, RH
    CARDIOVASCULAR RESEARCH, 2003, 59 (04) : 824 - 833
  • [5] Asymmetric Dimethylarginine: a Novel Cardiovascular Risk Factor in End-stage Renal Disease
    Alsagaff, M. Yusuf
    Thaha, M.
    Aminuddin, M.
    Yogiantoro, R. M.
    Yogiantoro, M.
    Tomino, Y.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2012, 40 (01) : 340 - 349
  • [6] Asymmetric dimethylarginine as a prospective risk factor for cardiovascular events in patients with coronary artery disease
    Schnabel, R.
    Lubos, E.
    Lackner, K. J.
    Rupprecht, H. J.
    Bickel, C.
    Tiret, L.
    Muenzel, T. F.
    Blankenberg, S.
    EUROPEAN HEART JOURNAL, 2005, 26 : 425 - 425
  • [7] Asymmetric dimethylarginine as a risk factor for cardiovascular disease in Japanese patients with type 2 diabetes mellitus
    Kanazawa, Ippei
    Yano, Shozo
    Notsu, Yoshitomo
    Yamaguchi, Toru
    Nabika, Toru
    Sugimoto, Toshitsugu
    CLINICAL ENDOCRINOLOGY, 2011, 74 (04) : 467 - 472
  • [8] LIPOPROTEIN(A) IS AN INDEPENDENT RISK FACTOR FOR CARDIOVASCULAR-DISEASE IN HEMODIALYSIS-PATIENTS
    CRESSMAN, MD
    HEYKA, RJ
    PAGANINI, EP
    ONEIL, J
    SKIBINSKI, CI
    HOFF, HF
    CIRCULATION, 1992, 86 (02) : 475 - 482
  • [9] Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease
    Ueda S.
    Yamagishi S.-I.
    Matsumoto Y.
    Fukami K.
    Okuda S.
    Clinical and Experimental Nephrology, 2007, 11 (2) : 115 - 121
  • [10] Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease
    Schnabel, R
    Edith, L
    Lackner, KJ
    Rupprecht, HJ
    Espinola-Klein, C
    Jachmann, N
    Bickel, C
    Cambien, F
    Tiret, L
    Münzel, TF
    Blankenberg, S
    CIRCULATION, 2005, 112 (17) : U870 - U870
12345